JD Health stock reports stable share count as margins improve
Published on 10/08/2026 at 05:59 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
JD Health reported 3.19 billion issued ordinary shares and no change in its share capital through September 30, 2026. The monthly filing also confirmed compliance with Hong Kong's 25 percent minimum public-float requirement, according to Futunn on October 7, 2026.
Share count stays unchanged
The filing gives investors a clean capital-structure reference: JD Health had no treasury shares and made no monthly change to its issued ordinary shares. That removes dilution from the immediate earnings discussion, leaving operating performance and valuation as the more important variables.
The company had reported first-half 2026 revenue of CNY 40.90 billion, an increase of 15.90 percent from the prior-year period. Non-IFRS operating profit rose 40.30 percent to CNY 3.50 billion, while operating margin improved from 7.00 percent to 8.50 percent, according to IT BOLTWISE on October 7, 2026.
Profit growth outpaces revenue
The comparison is the key signal. Operating profit expanded more than twice as fast as revenue, while first-half net profit increased 32.40 percent to CNY 3.44 billion. The margin improvement therefore matters more than sales growth alone because it shows stronger earnings conversion in the reported period.
For investors, the next test is whether the 8.50 percent operating margin holds as JD Health expands online pharmacy, telemedicine and health-management services. A separate Simply Wall St update dated October 5, 2026, lowered its fair value from HKD 91.27 to HKD 90.40 and highlighted AI agents, specialty drugs and higher-margin care services.
Stock remains below yearly high
JD Health stock was last at HKD 35.14 on the Hong Kong Stock Exchange on October 6, 2026 at 4:08 p.m. HKT, up HKD 0.32 or 0.92 percent from the prior close. The session range was HKD 34.98 to HKD 35.72, while the 52-week range stood at HKD 31.84 to HKD 71.70 and market capitalization was HKD 112.8 billion.
JD Health stock facts
- Company: JD Health International Inc.
- ISIN: KYG5074A1004
- Ticker: 6618
- Trading venue: HKSE
- Price (as of October 6, 2026, 4:08 p.m. HKT): HKD 35.14
- Market capitalization: HKD 112.8 billion (as of October 6, 2026)
- 52-week range: HKD 31.84-HKD 71.70 (as of October 6, 2026)
- Sector / Industry: Healthcare / Medical - Pharmaceuticals
More news and analyses on JD Health stock are available on the JD Health stock topic page.
